Hjem › Endetarmskreft › Ohio › Columbus
Kliniske studier for Endetarmskreft i Columbus, OH
10 studier for Endetarmskreft søker deltakere på steder i og rundt Columbus (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Rekrutterer
- Ohio State University Comprehensive Cancer Center, Columbus
Post-Market Study of the Signia Circular Stapler With Tri-Staple Technology in Left-sided Colon, Sigmoid, and Rectal Resections
Rekrutterer
- The Ohio State University Wexner Medical Center, Columbus
ColoSeal™ ICD System Anastomotic Protection Pivotal Study
Rekrutterer
- Ohio State Medical University Center, Columbus
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
RekruttererFase 3
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
Rekrutterer
- Ohio State University Comprehensive Cancer Center, Columbus
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
RekruttererFase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
RekruttererFrivillige helsepersonell ønskes velkommen
- Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- The Ohio State University, Columbus
Endetarmskreft-studier i andre byer
- New York City, NY17 studier
- Boston, MA12 studier
- Houston, TX11 studier
- St. Louis, MO11 studier
- Los Angeles, CA10 studier
- Seattle, WA9 studier
- Tampa, FL9 studier
- Nashville, TN9 studier
- Rochester, MN8 studier
- Chicago, IL8 studier
- Edison, NJ8 studier
- Salt Lake City, UT8 studier
Andre studier i Columbus
- Ikke-småcellet lungekreft56 studier
- Brystkreft39 studier
- Eggstokkreft39 studier
- Kreft (alle typer)38 studier
- Lungekreft37 studier
- Akut myelogen leukemi35 studier
- Kronisk lymfatisk leukemi28 studier
- Metastatisk kreft27 studier
- Endometriekreft25 studier
- Kolorektal kreft24 studier
- Prostatakreft24 studier
- Multipelt myelom24 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.